The Anticonvulsants Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the anticonvulsants market has consistently expanded over recent years. The market is projected to increase from $18.85 billion in 2024 to $19.44 billion in 2025, with a compound annual growth rate (CAGR) of 3.1%.
The Anticonvulsants Global Market is projected to reach a market size of $22.72 billion in 2029. The market is also forecast to grow at a compound annual growth rate of 4.0%.
Download Your Free Sample of the 2025 Anticonvulsants Market Report and Uncover Key Trends Now!The key drivers in the anticonvulsants market are:
• Continuing increase in epilepsy cases
• Expanding applications of anticonvulsants in neuropsychiatry
• Development of new anticonvulsant agents
• Increased emphasis on mental health and global health initiatives.
The anticonvulsants market covered in this report is segmented –
1) By Type: Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types
2) By Drug Generation: First Generation, Second Generation, Third Generation
3) By Dosage: Capsule, Tablet, Cream, Liquid, Rectal Gel, Other Dosages
4) By Application: Migraine, Epilepsy, Neuropathic Pain, Anxiety, Fibromyalgia, Bipolar Disorder, Borderline Personality Disorder
5) By End-User: Hospitals, Clinics, Other End-Users
The key trends in the anticonvulsants market are:
• The development of new anticonvulsant agents is shaping the future of the market.
• The integration of anticonvulsants with digital health solutions is becoming increasingly prevalent.
• There is increased emphasis on researching neuroprotective effects.
• The market is driven by a shift towards extended-release formulations and growing adoption of generic versions.
The major players in the anticonvulsants market are:
• Eisai Co Ltd
North America was the largest region in the anticonvulsants market in 2024